{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:08:44Z","timestamp":1786975724205,"version":"build-2736575974"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:sec id=\"ab-eoi240020-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Most neovascular age-related macular degeneration (nAMD) treatments involve long-term follow-up of disease activity. Home-monitoring would reduce the burden on patients and their caregivers and release clinic capacity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240020-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate 3 vision home-monitoring tests for patients to use to detect active nAMD compared with diagnosing active nAMD at hospital follow-up during the after-treatment monitoring phase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240020-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This was a diagnostic test accuracy study wherein the reference standard was detection of active nAMD by an ophthalmologist at hospital follow-up. The 3 home-monitoring tests evaluated included the following: (1) the KeepSight Journal (KSJ [International Macular and Retinal Foundation]), which contains paper-based near-vision tests presented as word puzzles, (2) the MyVisionTrack (mVT [Genentech]) vision-monitoring mobile app, viewed on an Apple mobile operating system\u2013based device, and (3) the MultiBit (MBT [Visumetrics]) app, viewed on an Apple mobile operating system\u2013based device. Participants were asked to test weekly; mVT and MBT scores were transmitted automatically, and KSJ scores were returned to the research office every 6 months. Raw scores between hospital follow-ups were summarized as averages. Patients were recruited from 6 UK hospital eye clinics and were 50 years and older with at least 1 eye first treated for active nAMD for at least 6 months or longer to a maximum of 42 months before approach. Participants were stratified by time since starting treatment. Study data were analyzed from May to September 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240020-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>The KSJ, mVT, and MBT were compared with the reference standard (in-hospital ophthalmologist examination).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240020-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Estimated area under receiver operating characteristic curve (AUROC). The study had 90% power to detect a difference of 0.06, or 80% power to detect a difference of 0.05, if the AUROC for 2 tests was 0.75.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240020-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 297 patients (mean [SD] age, 74.9 [6.6] years; 174 female [58.6%]) were included in the study. At least 1 hospital follow-up was available for 312 study eyes in 259 participants (1549 complete visits). Median (IQR) home-monitoring testing frequency was 3 (1-4) times per month. Estimated AUROC was less than 0.6 for all home-monitoring tests, and only the KSJ summary score was associated with lesion activity (odds ratio,\u20093.48; 95% CI, 1.09-11.13;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.04).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240020-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Results suggest that no home-monitoring vision test evaluated provided satisfactory diagnostic accuracy to identify active nAMD diagnosed in hospital eye service follow-up clinics. Implementing any of these evaluated tests, with ophthalmologists only reviewing test positives, would mean most active lesions were missed, risking unnecessary sight loss.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2024.0918","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T11:36:14Z","timestamp":1714044974000},"page":"512","source":"Crossref","is-referenced-by-count":16,"title":["Home-Monitoring Vision Tests to Detect Active Neovascular Age-Related Macular Degeneration"],"prefix":"10.1001","volume":"142","author":[{"given":"Ruth E.","family":"Hogg","sequence":"first","affiliation":[{"name":"Center for Public Health, Queen\u2019s University Belfast, Belfast, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[{"name":"NIHR Moorfields Biomedical Research Center, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Wickens","sequence":"additional","affiliation":[{"name":"Bristol Trials Center, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"O\u2019Connor","sequence":"additional","affiliation":[{"name":"Center for Public Health, Queen\u2019s University Belfast, Belfast, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Gidman","sequence":"additional","affiliation":[{"name":"Bristol Trials Center, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ward","sequence":"additional","affiliation":[{"name":"Bristol Trials Center, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Treanor","sequence":"additional","affiliation":[{"name":"Center for Public Health, Queen\u2019s University Belfast, Belfast, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunde","family":"Peto","sequence":"additional","affiliation":[{"name":"Center for Public Health, Queen\u2019s University Belfast, Belfast, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J. L.","family":"Burton","sequence":"additional","affiliation":[{"name":"James Paget University Hospitals NHS Trust, Great Yarmouth, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Knox","sequence":"additional","affiliation":[{"name":"University of Liverpool, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lotery","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Center for Public Health, Queen\u2019s University Belfast, Belfast, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris A.","family":"Rogers","sequence":"additional","affiliation":[{"name":"Bristol Trials Center, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnaby C.","family":"Reeves","sequence":"additional","affiliation":[{"name":"Bristol Trials Center, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"eoi240020r1","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/bjophthalmol-2019-314422","article-title":"Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysis.","volume":"104","author":"Li","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"eoi240020r2","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/08820538.2016.1181192","article-title":"Risk Factors for poor quality of life among patients with age-related macular degeneration.","volume":"32","author":"Chatziralli","year":"2017","journal-title":"Semin Ophthalmol"},{"issue":"12","key":"eoi240020r4","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1016\/j.ophtha.2015.08.015","article-title":"Association of baseline characteristics and early vision response with 2-year vision outcomes in the comparison of AMD treatments trials (CATT).","volume":"122","author":"Ying","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"eoi240020r5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1167\/tvst.7.5.32","article-title":"Home monitoring of retinal sensitivity on a tablet device in intermediate age-related macular degeneration.","volume":"7","author":"Adams","year":"2018","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"eoi240020r6","first-page":"320","article-title":"Improved adherence to vision self-monitoring with the vision and memory stimulating (VMS) journal for non-neovascular age-related macular degeneration during a randomized controlled trial.","volume":"5","author":"Bittner","year":"2014","journal-title":"J Clin Exp Ophthalmol"},{"issue":"10","key":"eoi240020r7","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.ophtha.2005.06.008","article-title":"Preferential hyperacuity perimeter (PreView PHP) for detecting choroidal neovascularization study.","volume":"112","author":"Alster","year":"2005","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi240020r8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/ICU.0000000000000756","article-title":"Current status of home monitoring technology for age-related macular degeneration.","volume":"32","author":"Busquets","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"issue":"11","key":"eoi240020r9","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1038\/s41433-020-01356-2","article-title":"False alarms and the positive predictive value of smartphone-based hyperacuity home monitoring for the progression of macular disease: a prospective cohort study.","volume":"35","author":"Faes","year":"2021","journal-title":"Eye (Lond)"},{"issue":"1","key":"eoi240020r10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjhci-2020-100310","article-title":"Smartphone-based remote monitoring of vision in macular disease enables early detection of worsening pathology and need for intravitreal therapy.","volume":"28","author":"Islam","year":"2021","journal-title":"BMJ Health Care Inform"},{"issue":"2","key":"eoi240020r11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jamaophthalmol.2021.5269","article-title":"Enablers and barriers to deployment of smartphone-based home vision monitoring in clinical practice settings.","volume":"140","author":"Korot","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"eoi240020r12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1113\/tjp.2016.594.issue-3","article-title":"Relationship between retinal blood flow and arterial oxygen.","volume":"594","author":"Cheng","year":"2016","journal-title":"J Physiol"},{"issue":"2","key":"eoi240020r13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41433-020-0910-4","article-title":"Monitoring for neovascular age-related macular degeneration (AMD) reactivation at home: the MONARCH study.","volume":"35","author":"Ward","year":"2021","journal-title":"Eye (Lond)"},{"issue":"20","key":"eoi240020r14","doi-asserted-by":"publisher","first-page":"13714","DOI":"10.3390\/ijerph192013714","article-title":"Patient acceptability of home monitoring for neovascular age-related macular degeneration reactivation: a qualitative study.","volume":"19","author":"O\u2019Connor","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"eoi240020r15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ophtha.2013.10.027","article-title":"Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the eye (HOME) study.","volume":"121","author":"Chew","year":"2014","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi240020r17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/eye.2011.326","article-title":"Environmental Amsler test as a monitoring tool for retreatment with ranibizumab for neovascular age-related macular degeneration.","volume":"26","author":"Mathew","year":"2012","journal-title":"Eye (Lond)"},{"issue":"8","key":"eoi240020r18","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.1167\/iovs.13-12037","article-title":"Handheld shape discrimination hyperacuity test on a mobile device for remote monitoring of visual function in maculopathy.","volume":"54","author":"Wang","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"eoi240020r19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-077196","article-title":"Descriptive study of the challenges when implementing an app for patients with neovascular age-related macular degeneration to monitor their vision at home.","volume":"14","author":"Reeves","year":"2024","journal-title":"BMJ Open"},{"issue":"3","key":"eoi240020r21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/bimj.v50:3","article-title":"Youden Index and optimal cut point estimated from observations affected by a lower limit of detection.","volume":"50","author":"Ruopp","year":"2008","journal-title":"Biom J"},{"key":"eoi240020r22","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies.","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"issue":"3","key":"eoi240020r23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/tvst.13.3.2","article-title":"Inequalities in uptake and use of digital applications for home-monitoring of neovascular AMD in an elderly visually impaired population: the MONARCH study.","volume":"13","author":"Hogg","year":"2024","journal-title":"Transl Vis Sci Technol"},{"key":"eoi240020r3","unstructured":"National Institute for Health and Care Excellence. Age-related macular degeneration. Accessed December 23, 2023. https:\/\/www.nice.org.uk\/guidance\/ng82"},{"key":"eoi240020r16","unstructured":"KeepSight. Home page. Accessed December 14, 2023. http:\/\/www.keepsight.com"},{"key":"eoi240020r20","unstructured":"NetwORC UK. Welcome to NetwORC UK. Accessed April 4, 2023. https:\/\/www.networcuk.com\/"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2817623\/jamaophthalmology_hogg_2024_oi_240020_1718141454.01286.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T11:08:52Z","timestamp":1718881732000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2817623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.0918","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}